Marvin Hausman
Chief Executive Officer at LUDWIG ENTERPRISES, INC.
Net worth: 13 M $ as of 30/04/2024
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Thomas Terwilliger | M | - | 1 years | |
Anthony S. Crisci | M | 54 | - | |
Merrill McPeak | M | 88 | 13 years | |
Patrick Greenish | M | - | - | |
Brian T. McGee | M | 63 | - | |
Jean Cherubin | M | - | - | |
Joseph Moscato | M | 61 | 7 years | |
Craig Eagle | M | 57 | - | |
Richard Purcell | M | 63 | 7 years | |
Carol A. Nacy | M | 76 | - | |
Eric von Hofe | M | 66 | - | |
Scott Silverman | M | 54 | 1 years | |
Thomas Leonard | M | 50 | - | |
Georg Hochwimmer | M | 56 |
Pilz Biosciences Corp.
Pilz Biosciences Corp. BiotechnologyHealth Technology Pilz Biosciences Corp. operates as a biotechnology company. The firm develops medicinal psychedelics for neuroinflammatory conditions with a significant cognitive component and high unmet therapeutic needs. The company is headquartered in Vancouver, BC. | - |
Mark Corrao | M | 67 | - | |
David Cohen | M | 59 |
New York University
| 30 years |
Bodhan Stryzak | M | - | - | |
Steven R. Goldstein | M | 73 |
New York University
| 29 years |
Jason Terrell | M | 43 | - | |
Georg Hochwimmer, PhD | - | - |
Pilz Biosciences Corp.
Pilz Biosciences Corp. BiotechnologyHealth Technology Pilz Biosciences Corp. operates as a biotechnology company. The firm develops medicinal psychedelics for neuroinflammatory conditions with a significant cognitive component and high unmet therapeutic needs. The company is headquartered in Vancouver, BC. | - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Anthony Cataldo | M | 73 | 2 years | |
Steven B. Ratoff | M | 81 |
TorreyPines Therapeutics, Inc.
TorreyPines Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology TorreyPines Therapeutics, Inc. manufactures and distributes biopharmaceutical products. The company develops small molecule drugs to treat diseases and disorders of the central nervous system, chronic pain, neuropathic pain, cognitive disorders and alzheimer's disease. It was formerly known as Axonyx, Inc. The company is headquartered in La Jolla, CA.
Axonyx, Inc.
Axonyx, Inc. Pharmaceuticals: MajorHealth Technology Axonyx, Inc. is an biopharmaceutical company, which manufactures medical products and technologies to treat Alzheimer's disease and other Central Nervous System disorders. It is located in New York, NY. | 4 years |
Gary Post | M | 76 | - | |
Manish Singh | M | 56 | 1 years | |
Gosse Bote Bruinsma | M | 69 |
Axonyx, Inc.
Axonyx, Inc. Pharmaceuticals: MajorHealth Technology Axonyx, Inc. is an biopharmaceutical company, which manufactures medical products and technologies to treat Alzheimer's disease and other Central Nervous System disorders. It is located in New York, NY. | - |
Sydney Colin Neill | M | 77 |
Axonyx, Inc.
Axonyx, Inc. Pharmaceuticals: MajorHealth Technology Axonyx, Inc. is an biopharmaceutical company, which manufactures medical products and technologies to treat Alzheimer's disease and other Central Nervous System disorders. It is located in New York, NY. | 3 years |
Steven H. Ferris | M | 80 |
Axonyx, Inc.
Axonyx, Inc. Pharmaceuticals: MajorHealth Technology Axonyx, Inc. is an biopharmaceutical company, which manufactures medical products and technologies to treat Alzheimer's disease and other Central Nervous System disorders. It is located in New York, NY.
TorreyPines Therapeutics, Inc.
TorreyPines Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology TorreyPines Therapeutics, Inc. manufactures and distributes biopharmaceutical products. The company develops small molecule drugs to treat diseases and disorders of the central nervous system, chronic pain, neuropathic pain, cognitive disorders and alzheimer's disease. It was formerly known as Axonyx, Inc. The company is headquartered in La Jolla, CA. | 6 years |
Neil M. Kurtz | M | 73 |
TorreyPines Therapeutics, Inc.
TorreyPines Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology TorreyPines Therapeutics, Inc. manufactures and distributes biopharmaceutical products. The company develops small molecule drugs to treat diseases and disorders of the central nervous system, chronic pain, neuropathic pain, cognitive disorders and alzheimer's disease. It was formerly known as Axonyx, Inc. The company is headquartered in La Jolla, CA. | 5 years |
Andrey Valentin Krakovsky | M | - |
New York University
| - |
Nam-Kyu Park | M | 58 |
New York University
| 5 years |
William John Reininger | M | 72 | 2 years | |
John Calaba | M | - |
New York University
| 13 years |
Nicholas P. Johns | M | - |
New York University
| 6 years |
William H. Andrews | M | 71 | 2 years | |
David J. Voyticky | M | 54 | 2 years | |
Glen M. Doniger | M | - |
New York University
| 3 years |
Pat M. Patalino | M | - |
New York University
| 3 years |
Anthony Power | M | 57 |
New York University
| 6 years |
Eitan Leger | M | - |
New York University
| 11 years |
Ira S. Gerstein | M | - |
New York University
| 4 years |
L. Stephen Coles | M | 72 | 2 years | |
Kelly P. W. Clark | F | - |
New York University
| - |
Paul Audhya | M | 51 |
New York University
| 8 years |
Yu Wu Wu | M | 63 |
New York University
| 3 years |
Sok-Ho Jung | M | 59 |
New York University
| 6 years |
Paul J. Kim | M | - |
New York University
| 7 years |
Jay Venkatesan | M | 52 | 5 years | |
Sonny Weng | M | - |
New York University
| 6 years |
Michael J. Grippo | M | 55 |
New York University
| 4 years |
Sanford J. Hillsberg | M | 75 | 5 years | |
Steven T. Guillen | M | - | 2 years | |
Anne Blackstone | F | - | 1 years | |
Anoop Kumar | M | - |
New York University
| 7 years |
Natalie A. Trunow | F | - |
New York University
| 5 years |
Claudia Maria Amelia Copper Fort | F | 56 |
New York University
| 5 years |
Kristine F. Treglia | F | - |
New York University
| 5 years |
Noel Goddard | M | 49 |
New York University
| 4 years |
Geoffrey Bedrosian | M | 58 |
New York University
| - |
Igor Levin | M | - |
New York University
| 7 years |
Evelyn A. Graham | F | 75 |
TorreyPines Therapeutics, Inc.
TorreyPines Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology TorreyPines Therapeutics, Inc. manufactures and distributes biopharmaceutical products. The company develops small molecule drugs to treat diseases and disorders of the central nervous system, chronic pain, neuropathic pain, cognitive disorders and alzheimer's disease. It was formerly known as Axonyx, Inc. The company is headquartered in La Jolla, CA. | 3 years |
Baylor A. Lancaster-Samuel | F | - |
New York University
| 4 years |
Giovanni Caruso | M | - |
New York University
| 7 years |
Ralph J. Divino | M | - |
New York University
| 4 years |
Steinthal Tom | M | - |
New York University
| 4 years |
Larry D. Kramer | M | - |
New York University
| - |
Tao I. Ting | M | 61 |
New York University
| 2 years |
David Douglas Langfitt | M | - |
New York University
| 1 years |
Josh Nussbaum | M | - |
New York University
| 3 years |
Daren R. Roberts | M | - |
New York University
| 4 years |
Michael Harte | M | - |
New York University
| 2 years |
Lisa L. Fuller | F | 59 |
New York University
| 3 years |
Ashish Bhatia | M | - |
New York University
| 4 years |
Fred J. Adam | M | - |
New York University
| 3 years |
Edward Levin | M | - |
New York University
| 3 years |
David Park | M | - |
New York University
| 4 years |
Maggie O'Neill | F | - |
New York University
| 4 years |
Lane Bucklan | M | - |
New York University
| 3 years |
Woongkee Min | M | - |
New York University
| 3 years |
Steven Grin | M | - |
New York University
| 4 years |
William T. Comer | M | 85 |
TorreyPines Therapeutics, Inc.
TorreyPines Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology TorreyPines Therapeutics, Inc. manufactures and distributes biopharmaceutical products. The company develops small molecule drugs to treat diseases and disorders of the central nervous system, chronic pain, neuropathic pain, cognitive disorders and alzheimer's disease. It was formerly known as Axonyx, Inc. The company is headquartered in La Jolla, CA. | 1 years |
George G. Daly | M | 83 |
New York University
| 7 years |
Clem Garcia | M | - |
New York University
| - |
Herb Chen | M | - |
New York University
| 4 years |
Craig Charles Albert | M | - |
New York University
| 3 years |
Katrina S. Dudley | F | - |
New York University
| 2 years |
Daniel Volpi | M | - |
New York University
| 2 years |
Dave P. Reiss | M | - |
New York University
| 4 years |
John S. Neamonitis | M | - |
New York University
| 4 years |
Romas Garbaliauskas | M | - |
New York University
| 1 years |
Mark Groussman | M | 51 |
New York University
| 1 years |
Jennifer A. Duggins | F | - |
New York University
| 4 years |
Eric J. Gordon | M | - |
New York University
| 2 years |
Brian P. Donlin | M | - |
New York University
| 4 years |
Robert Buff | M | - |
New York University
| 5 years |
Seung-Ho Ahn | M | - |
New York University
| 4 years |
Joshua Koenig | M | - |
New York University
| 4 years |
Andre Abdi | M | 68 |
New York University
| 2 years |
Kan Zhou | M | - |
New York University
| 6 years |
Wallace Enman | M | - |
New York University
| 4 years |
Christie Smith | M | - |
New York University
| - |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 92 | 92.00% |
Canada | 2 | 2.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Marvin Hausman
- Personal Network